why choose us

First received: June 26, 2023

Clinical Trial: Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Neoplasms

Study Type: OBSERVATIONAL


Official Title: The VAginal Microbiome as a BiomaRker of VagInal Health in Women With BreaSt CancEr (ARISE)

Brief Summary: This study evaluates vaginal microbiome as a biomarker to improve vaginal and sexual health in women with breast cancer receiving endocrine therapy.Breast cancer is the most common cancer in United States women, aside from skin cancers.Endocrine therapy is standard treatment for 70% of invasive breast cancers, significantly affecting sexual health and often causing women to change their course of treatment or cease sexual activity.Changes in the vaginal microbiome, which is the collection of all microorganisms,…

Read more